The team is managing the BSL3 laboratory of Bordeaux University within the TBM core (CNRS-UMS3427 / INSERM US005). Marie-Line Andreola is scientific director and Patricia Pinson is technical director of the facility. Marie-Lise Blondot is a full-time engineer dedicated to SARS-COV-2 related experimentations.
- Compounds screening for antiviral activity against HIV, HCV, ZIKV and SARS-COV-2.
- Cellular mechanism of action of active compounds
- Oncogenes vectorization
- Cat3 GMOs handeling
for more details, please visit the UB’L3 website (in french).
Research projects involving the BSL3
ANACONDA (ANR project, PI ML Andreola)
VasCOV (ANR project, PI A Bikfalvi)
For more details about these projects, please visit the Andevir webpage.